Reser’s Fine Foods, Inc. of Beaverton, Oregon is recalling nineteen refrigerated salad items due to notification from one of our ingredient suppliers that Listeria monocytogenes may be present in one lot of onions that was used in the manufacture of these salads. Listeria monocytogenes is an organism which can cause serious and sometime fatal infections in young children, frail or elderly people and individuals with weakened immune systems.
Super Herbs Issues Voluntary Nationwide Recall Of SUPER HERBS Due To Presence Of Undeclared Sibutramine, Desmethylsibutramine and/or Phenolphthalein
Super Herbs is voluntarily recalling all bottles of SUPER HERBS, light green and dark green capsules to the consumer level after FDA laboratory testing found SUPER HERBS to contain sibutramine, desmethylsibutramine, and/or phenolphthalein.
Whole Foods Market Recalls Mislabeled Asparagus, Pea and Ricotta Salad Due to Undeclared Allergen
Whole Foods Market is recalling ten ounce packages of Asparagus, Pea and Ricotta salad because it was mislabeled and actually contained miniature Asparagus, Sun Dried Tomato and Swiss Frittatas. Due to the labeling error, an egg allergen was undeclared.
Dexcom, Inc., Issues Press Release to Supplement Previous Customer Notification
Dexcom, Inc. (NASDAQ: DXCM) issues this press release to supplement its previous customer notification and remind its patients to periodically test the audible alarms and alerts on certain receivers manufactured by Dexcom to make sure that the audible alarms and alerts are functioning properly. The notification constituted a voluntary recall and applied to those Dexcom G4 Platinum Receivers, Dexcom G4 Platinum Pediatric Receivers, Dexcom G4 Platinum Professional Receivers, Dexcom G4 Platinum with Share Receivers, Dexcom G4 Platinum with Share Pediatric Receivers and the Dexcom G5 Mobile Receivers that are experiencing problems with audible alarms and alerts.
Back to Nature Issues Allergy Alert for Limited Number of Classic Crème Cookies Due to Undeclared Milk
Back to Nature Foods, LLC is voluntarily recalling two (2) lots of its Classic Crème cookies, 12 oz packages, because it may contain undeclared milk, not listed as an ingredient on the label. Persons who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume this product.
Voluntary Recall of Fetch™ 2 Aspiration Catheter
Boston Scientific (NYSE: BSX) has initiated a global, voluntary recall of all models of its Fetch™ 2 Aspiration Catheter, a thrombectomy catheter used during procedures to remove small blood clots from coronary arteries. The Fetch 2 catheters were recalled on March 22, 2016, due to complaints of shaft breakage.
Vascular Solutions, Inc. Issues Recall of Guardian® II Hemostasis Valves
Vascular Solutions, Inc. (Nasdaq: VASC), initiated a nationwide recall of Guardian II hemostasis valves used in catheterization procedures. Specific lots of the products have been recalled because they pose an increased risk of air leakage that may lead to an air embolism, which could result in serious injury or death.
FDA approves new drug for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality
The U.S. Food and Drug Administration today approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have a chromosomal abnormality called 17p deletion and who have been treated with a least one prior therapy. Venclexta is the first FDA-approved treatment that targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with CLL.
Progressive Gourment Inc. Issues an Allergy Alert on Taste of Inspirations Edamame Rangoon Due to Possible Mislabeling and Undeclared Crustacean Shellfish
Progressive Gourmet Inc. of Wilmington, MA, is voluntarily recalling its frozen, 9 ounce packages of Taste of Inspirations Edamame Rangoon out of an abundance of caution because they have the potential to contain crustacean shellfish (crab). People who have an allergy to crustacean shellfish run the risk of serious or life-threatening allergic reaction if they consume these products.
Read The Complete Story!
FDA takes steps to withdraw approval of the swine drug carbadox due to safety concerns
Today, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) took the first step toward rescinding its approval of the use of carbadox to treat swine because the drug may leave trace amounts of a carcinogenic residue.